{"success":true,"type":"rich","version":"1.0","cache_age":86400,"width":440,"height":500,"provider_name":"RiffReporter","provider_url":"https:\/\/www.riffreporter.de","safety":"nonadult","asset_type":"article","url":"https:\/\/www.riffreporter.de\/de\/international\/suedafrika-impfstudie","category":"International","author_name":"Leonie March","author_url":"https:\/\/www.riffreporter.de\/de\/autorinnen-und-autoren\/leonie-march","title":"S\u00fcdafrika hofft auf einen Impfstoff - Die erste COVID-19-Impfstudie in Afrika","summary":"In S\u00fcdafrika ist von einem Meilenstein die Rede. Ende Juni hat die erste Covid-19-Impfstudie begonnen. \u00dcber Hoffnungen, Proteste und \u00dcberraschungen.","publication_date":"17.07.2020","thumbnail_url":"https:\/\/riff.media\/images\/suedafrika-corona-impfstudie-shabir-madhi-covid19-vaccine-trial.jpg?w=440&h=247&fit=crop-50-50&s=5d290765af321460a6e0af2bd039543f","thumbnail_width":440,"thumbnail_height":247,"thumbnail_credit":null,"thumbnail_credit_url":null,"thumbnail_credit_note":null,"html":"<html lang=\"de\"><iframe src=\"https:\/\/riff.media\/oembed?format=html&url=https%3A%2F%2Fwww.riffreporter.de%2Fde%2Finternational%2Fsuedafrika-impfstudie\" width=\"440\" height=\"550\" style=\"border: 0; width: 440px; height: 550px;\" allowtransparency=\"true\" allowfullscreen><\/iframe><\/html>"}